Jubliant Life Sciences

Jubilant Launched Remdesivir in India for COVID-19 Treatment

JUBI-R by Jubliant Life Sciences in Indian market is available at a price of Rs 4,700 and available to over 1,000 hospitals will be used for COVID-19.